Women Living With HIV Require Better Mental Health Diagnostics and Interventions
In a narrative review, researchers described various mental health interventions, and their feasibility and outcomes for WLWH.
Features
HIV and Inflammatory Bowel Disease: A Unique Patient Population
The authors review gut dysfunction and microbiota changes during HIV infection and IBD and discuss how they may induce a dysfunctional mucosal barrier, dysbiosis, and changes on the cellular level, including monocytes, macrophages, and dendritic cells.
A Conversation About Racial Disparities in Health Care With Dr Scharles Konadu
Clinical Pain Advisor met with Scharles Konadu, MD, a member of the American Board of Internal Medicine Gastroenterology Specialty Board, to discuss how deeply racial inequity is woven into our health care system.
WHO End Tuberculosis Strategy Progress Stalled in Light of COVID-19
The gains in the global fight against tuberculosis have been threatened as a result of the COVID-19 pandemic, including a diversion of resources that have led to disruptions in ongoing research and control programs.
Moral Judgments and COVID-19 Vaccine Hesitancy
Whatever strategy you employ to encourage vaccinations, it is important to be respectful and empathize with your patient’s concerns and perspectives.
Plant-Based Vaccine Manufacturing for Influenza, Implications for Future Vaccines
An emerging body of research highlights plant-based vaccine manufacturing as a potential solution to risks posed by traditional egg-based manufacturing.
COVID-19 Vaccines and Allergic Reactions: Data Analysis, What You Need to Know
Polyethylene glycol (PEG) found in mRNA-based COVID vaccines, Pfizer and Moderna, have excluded patients due to risk of allergic reactions, including anaphylaxis; the recent approval of Janssen’s COVID-19 vaccine, which contains polysorbate, provides an alternative for this population.
Long-Term Repercussions of Postponing Care Due to COVID-19
Fear of the COVID-19 pandemic has caused patients to cancel or delay necessary cancer screenings, diagnostic tests, wellness exams, elective surgeries, and immunizations; the repercussions of this may be immediate, or not seen for months to years.
COVID-19 Vaccine Efficacy After First Dose: Pfizer, Moderna, AstraZeneca
New data about Pfizer COVID-19 efficacy after the first dose suggests high efficacy, raising questions about potential alternative dosing schedules.
Oxford-AstraZeneca COVID-19 Vaccine: New Study Results, Variant Coverage Update, Where Do We Stand?
The Oxford-AstraZeneca COVID-19 vaccine, ChAdOx1, released 4 studies to analyze its efficacy in the prevention of mild, moderate, and severe COVID-19 infection; new studies also address rising concerns in the vaccine’s ability to protect against variants B.1.1.7 and B.1.351.
But Is it Fair? Bioethics, COVID-19 Vaccine Distribution, and Advocacy
We speak with Mildred Solomon, EdD, President of the Hastings Center and Professor of Global Health and Social Medicine at Harvard Medical School, where she directs the school’s Fellowship in Bioethics, about the COVID-19 pandemic, health equity, and vaccine distribution.
COVID-19 Variants: Pfizer, Moderna Updates, and IDSA Media Briefing
Moderna and Pfizer provide updates on mRNA vaccines against variant B.1.1.7; Infectious Diseases Society of America holds media briefing on COVID-19 variants.
Controversy: Protecting People Who Use Drugs During COVID-19
Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.
Expert Roundtable: Physician Burnout During COVID-19
Monisha Sharma, PhD, and Charlene Dewey, MD, provide insight into the current landscape that leads to physician burnout and the next steps to combat it.
Address Possible Security Lapses as Your Practice Returns to Normal
To accommodate patients remotely during the COVID-19 pandemic, practices may have expanded personnel access to protected health information and relied on devices that might be vulnerable to cyber attacks.
COVID-19: What Now, What’s Next?
George Abraham, MD, offers insight into where the United States currently stands with regard to the COVID-19 pandemic, vaccine development, barriers to care in various patient populations, and the evolving roles of infectious disease specialists.
COVID-19 Vaccine Allocation: Ethical Concerns, Practical Challenges
In the event of a likely scarcity of COVID-19 vaccines, a framework must be developed to inform who should get priority.
ACTIV-2 and Operation Warp Speed: An Interview With COVID-19 Investigator, Davey Smith, MD
Davey Smith, MD, provides insight into current and future research opportunities targeting SARS-CoV-2.
How the Coronavirus Pandemic May Affect Cancer Clinical Trials
Risks of moving clinical trials online include missing key information about the patient experience — and higher dropout rates could also impair the overall quality of trials.
5 Ways COVID-19 Is Changing Clinical Ophthalmic Care
The current COVID-19 pandemic requires rethinking some procedural protocols in ophthalmology practice.
BCG Tuberculosis Vaccine: Potential Protection Against COVID-19
Findings suggest lower rates of COVID-19 infection and mortality in countries with universal neonatal BCG tuberculosis vaccination policies compared with countries without this practice.
IT Asset Inventories Are a First Step in Securing Health Information
Practices need to know all of the components of their health information systems to determine potential vulnerabilities.
Dermatologic Challenges to Preventing Antimicrobial Resistance During the COVID-19 Pandemic
The COVID-19 pandemic has illuminated an ongoing concern about antimicrobial resistance in dermatology and requires a recommitment from clinicians to follow guidelines that promote good stewardship.
Ethical Considerations in Prescribing Unproven Therapies for COVID-19
Meeting public demand for an urgently needed effective medication quickly and safely during a pandemic involves difficult tradeoffs.
Tick-Borne Illnesses: Rising Incidence, Rising Concerns
Experts examine the reasoning behind a steep rise in tick-borne illnesses, such as Lyme disease, in the United States and discuss the best ways to thwart this serious public health threat.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Features
